Discover
CPRX
Catalyst Pharmaceuticals, Inc.
31.44
13 x 31.43
1 x 35.86
bid
ask
+
0.01
0.03%
7 @ 04:00 PM
31.30 -0.14 (0.45%)
| Ytd | 34.70% | |
| 1y | 48.37% |
31.43
day range
31.46
19.05
52 week range
32.56
| Open | 31.45 | Prev Close | 31.43 | Low | 31.43 | High | 31.46 | Mkt Cap | 3.85B |
| Vol | 783.44K | Avg Vol | 2.33M | EPS | 1.73 | P/E | 18.17 | Forward P/E | 9.88 |
| Beta | 0.74 | Short Ratio | 3.99 | Inst. Own | 89.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 30.61 | 200-d Avg | 24.89 | 1yr Est | 31.67 |
| Income Statement | |||
| Total Revenue | 149.39M | ||
| Revenues (USD) | 149.39M | ||
| Cost of Revenue | 14.48M | ||
| Gross Profit | 134.92M | ||
| Operating Expenses | 61.68M | ||
| Research and Development Expense | 2.66M | ||
| Selling, General and Administrative Expense | 49.32M | ||
| Operating Income | 73.23M | ||
| Income Tax Expense | 20.50M | ||
| Net Income | 63.73M | ||
| Net Income Common Stock | 63.73M | ||
| Net Income Common Stock (USD) | 63.73M | ||
| Consolidated Income | 63.73M | ||
| Earnings per Basic Share | 0.52 | ||
| Earnings per Basic Share (USD) | 0.52 | ||
| Earnings per Diluted Share | 0.50 | ||
| Earning Before Interest & Taxes (EBIT) | 84.23M | ||
| Earning Before Interest & Taxes (USD) | 84.23M | ||
| Weighted Average Shares | 122.25M | ||
| Weighted Average Shares Diluted | 126.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 755.86M | ||
| Cash and Equivalents (USD) | 755.86M | ||
| Investments | 27.29M | ||
| Investments Non-Current | 27.29M | ||
| Trade and Non-Trade Receivables | 130.83M | ||
| Current Assets | 940.39M | ||
| Property, Plant & Equipment Net | 2.85M | ||
| Total Assets | 1.15B | ||
| Total Debt | 2.24M | ||
| Current Liabilities | 132.40M | ||
| Debt Non-Current | 2.24M | ||
| Total Liabilities | 134.91M | ||
| Accumulated Retained Earnings (Deficit) | 523.35M | ||
| Accumulated Other Comprehensive Income | 8.00K | ||
| Shareholders Equity | 1.01B | ||
| Shareholders Equity (USD) | 1.01B | ||
| Assets Non-Current | 207.22M | ||
| Total Debt (USD) | 2.24M | ||
| Goodwill and Intangible Assets | 121.97M | ||
| Inventory | 34.93M | ||
| Liabilities Non-Current | 2.52M | ||
| Trade and Non-Trade Payables | 7.15M | ||
| Tax Assets | 55.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.85M | ||
| Net Cash Flow from Financing | -12.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 46.69M | ||
| Capital Expenditure | -27.00K | ||
| Issuance (Purchase) of Equity Shares | -11.27M | ||
| Net Cash Flow from Investing | -27.00K | ||
| Net Cash Flow from Operations | 59.59M | ||
| Share Based Compensation | 6.26M | ||